Rapamycin attenuates pathological hypertrophy caused by an absence of trabecular formation

Cardiac trabeculae are mesh-like muscular structures within ventricular walls. Subtle perturbations in trabeculation are associated with many congenital heart diseases (CHDs), and complete failure to form trabeculae leads to embryonic lethality. Despite the severe consequence of an absence of trabec...

Full description

Saved in:
Bibliographic Details
Main Authors: Fleming, Nicole D (Author) , Samsa, Leigh A. (Author) , Hassel, David (Author) , Qian, Li (Author) , Liu, Jiandong (Author)
Format: Article (Journal)
Language:English
Published: 05 June 2018
In: Scientific reports
Year: 2018, Volume: 8
ISSN:2045-2322
DOI:10.1038/s41598-018-26843-1
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41598-018-26843-1
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41598-018-26843-1
Get full text
Author Notes:Nicole D. Fleming, Leigh A. Samsa, David Hassel, Li Qian & Jiandong Liu

MARC

LEADER 00000caa a2200000 c 4500
001 1695643631
003 DE-627
005 20230426080128.0
007 cr uuu---uuuuu
008 200422s2018 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41598-018-26843-1  |2 doi 
035 |a (DE-627)1695643631 
035 |a (DE-599)KXP1695643631 
035 |a (OCoLC)1341316371 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Fleming, Nicole D  |e VerfasserIn  |0 (DE-588)1208802178  |0 (DE-627)1695645537  |4 aut 
245 1 0 |a Rapamycin attenuates pathological hypertrophy caused by an absence of trabecular formation  |c Nicole D. Fleming, Leigh A. Samsa, David Hassel, Li Qian & Jiandong Liu 
264 1 |c 05 June 2018 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.04.2020 
520 |a Cardiac trabeculae are mesh-like muscular structures within ventricular walls. Subtle perturbations in trabeculation are associated with many congenital heart diseases (CHDs), and complete failure to form trabeculae leads to embryonic lethality. Despite the severe consequence of an absence of trabecular formation, the exact function of trabeculae remains unclear. Since ErbB2 signaling plays a direct and essential role in trabecular initiation, in this study, we utilized the erbb2 zebrafish mutant as a model to address the function of trabeculae in the heart. Intriguingly, we found that the trabeculae-deficient erbb2 mutant develops a hypertrophic-like (HL) phenotype that can be suppressed by inhibition of Target of Rapamycin (TOR) signaling in a similar fashion to adult mammalian hearts subjected to mechanical overload. Further, cell transplantation experiments demonstrated that erbb2 mutant cells in an otherwise wildtype heart did not undergo hypertrophy, indicating that erbb2 mutant HL phenotypes are due to a loss of trabeculae. Together, we propose that trabeculae serve to enhance contractility and that defects in this process lead to wall-stress induced hypertrophic remodeling. 
700 1 |a Samsa, Leigh A.  |e VerfasserIn  |4 aut 
700 1 |a Hassel, David  |e VerfasserIn  |0 (DE-588)135801613  |0 (DE-627)693785608  |0 (DE-576)300653808  |4 aut 
700 1 |a Qian, Li  |e VerfasserIn  |4 aut 
700 1 |a Liu, Jiandong  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Scientific reports  |d [London] : Springer Nature, 2011  |g 8(2018) Article number: 8584, 10 Seiten  |h Online-Ressource  |w (DE-627)663366712  |w (DE-600)2615211-3  |w (DE-576)346641179  |x 2045-2322  |7 nnas  |a Rapamycin attenuates pathological hypertrophy caused by an absence of trabecular formation 
773 1 8 |g volume:8  |g year:2018  |g extent:10  |a Rapamycin attenuates pathological hypertrophy caused by an absence of trabecular formation 
856 4 0 |u https://doi.org/10.1038/s41598-018-26843-1  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41598-018-26843-1  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200422 
993 |a Article 
994 |a 2018 
998 |g 135801613  |a Hassel, David  |m 135801613:Hassel, David  |d 50000  |e 50000PH135801613  |k 0/50000/  |p 3 
999 |a KXP-PPN1695643631  |e 3630016448 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1695643631"],"doi":["10.1038/s41598-018-26843-1"]},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"05 June 2018"}],"name":{"displayForm":["Nicole D. Fleming, Leigh A. Samsa, David Hassel, Li Qian & Jiandong Liu"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"2011-","publisher":"Springer Nature ; Nature Publishing Group","dateIssuedKey":"2011","publisherPlace":"[London] ; London"}],"id":{"zdb":["2615211-3"],"eki":["663366712"],"issn":["2045-2322"]},"pubHistory":["1, article number 1 (2011)-"],"part":{"volume":"8","text":"8(2018) Article number: 8584, 10 Seiten","extent":"10","year":"2018"},"note":["Gesehen am 12.07.24"],"disp":"Rapamycin attenuates pathological hypertrophy caused by an absence of trabecular formationScientific reports","type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"recId":"663366712","title":[{"title_sort":"Scientific reports","title":"Scientific reports"}]}],"physDesc":[{"extent":"10 S."}],"title":[{"title_sort":"Rapamycin attenuates pathological hypertrophy caused by an absence of trabecular formation","title":"Rapamycin attenuates pathological hypertrophy caused by an absence of trabecular formation"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Fleming, Nicole D","given":"Nicole D","family":"Fleming"},{"given":"Leigh A.","family":"Samsa","role":"aut","roleDisplay":"VerfasserIn","display":"Samsa, Leigh A."},{"display":"Hassel, David","roleDisplay":"VerfasserIn","role":"aut","family":"Hassel","given":"David"},{"family":"Qian","given":"Li","roleDisplay":"VerfasserIn","display":"Qian, Li","role":"aut"},{"given":"Jiandong","family":"Liu","role":"aut","display":"Liu, Jiandong","roleDisplay":"VerfasserIn"}],"recId":"1695643631","language":["eng"],"note":["Gesehen am 22.04.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a FLEMINGNICRAPAMYCINA0520